Literature DB >> 33800276

Significant Associations of lncRNA H19 Genotypes with Susceptibility to Childhood Leukemia in Taiwan.

Jen-Sheng Pei1, Chao-Chun Chen1, Wen-Shin Chang2,3, Yun-Chi Wang2,3, Jaw-Chyun Chen4, Yu-Chen Hsiau3, Pei-Chen Hsu1, Yuan-Nian Hsu5, Chia-Wen Tsai2,3, Da-Tian Bau2,3,6.   

Abstract

The purpose of our study was to investigate whether genetic variations in lncRNA H19 were associated with susceptibility to childhood leukemia. Two hundred and sixty-six childhood leukemia patients and 266 healthy controls were enrolled in Taiwan, and two single nucleotide polymorphisms (SNPs), rs2839698 and rs217727, in H19 were genotyped and analyzed. There was a significant difference in the genotypic distribution of rs2839698 between patients and healthy controls (p = 0.0277). Compared to the wild-type CC genotype, the heterozygous variant CT and homozygous variant TT genotypes were associated with significantly increased risks of childhood leukemia with an adjusted odd ratio (OR) of 1.46 (95% confidence interval (CI), 1.08-2.14, p = 0.0429) and 1.94 (95%CI, 1.15-3.31, p = 0.0169), respectively (pfor tread = 0.0277). The difference in allelic frequencies between childhood leukemia patients and controls was also significant (T versus C, adjusted OR = 1.53, 95%CI, 1.13-1.79, p = 0.0077). There were no significant differences in the genotypic and allelic distributions of rs217727 between cases and controls. Interestingly, the average level of H19 rs2839698 was statistically significantly higher for patients with CT and TT genotypes than from those with the CC genotype (p < 0.0001). Our results indicate that H19 SNP rs2839698, but not rs217727, may serve as a novel susceptibility marker for childhood leukemia.

Entities:  

Keywords:  H19; SNP; Taiwan; childhood leukemia; genetic susceptibility; lncRNA

Year:  2021        PMID: 33800276      PMCID: PMC7999603          DOI: 10.3390/ph14030235

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN: 1424-8247


  55 in total

Review 1.  The H19 locus: role of an imprinted non-coding RNA in growth and development.

Authors:  Anne Gabory; Hélène Jammes; Luisa Dandolo
Journal:  Bioessays       Date:  2010-06       Impact factor: 4.345

2.  Significant Association Between the MiR146a Genotypes and Susceptibility to Childhood Acute Lymphoblastic Leukemia in Taiwan.

Authors:  Jen-Sheng Pei; Wen-Shin Chang; Pei-Chen Hsu; Chao-Chun Chen; Yu-Ting Chin; Tai-Lin Huang; Yuan-Nian Hsu; Chien-Chung Kuo; Yun-Chi Wang; Chia-Wen Tsai; Chi-Li Gong; DA-Tian Bau
Journal:  Cancer Genomics Proteomics       Date:  2020 Mar-Apr       Impact factor: 4.069

3.  Quantitative assessment of lncRNA H19 polymorphisms and cancer risk: a meta-analysis based on 48,166 subjects.

Authors:  Xu Liu; Yating Zhao; Ying Li; Jian Zhang
Journal:  Artif Cells Nanomed Biotechnol       Date:  2020-12       Impact factor: 5.678

4.  H19 promotes the gastric carcinogenesis by sponging miR-29a-3p: evidence from lncRNA-miRNA-mRNA network analysis.

Authors:  Jianxin Li; Xin Wang; Yinchun Wang; Qingqiang Yang
Journal:  Epigenomics       Date:  2020-05-20       Impact factor: 4.778

5.  Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression.

Authors:  Ming Luo; Zuowei Li; Wei Wang; Yigang Zeng; Zhihong Liu; Jianxin Qiu
Journal:  FEBS J       Date:  2013-03-06       Impact factor: 5.542

6.  LncRNA H19 polymorphisms associated with the risk of OSCC in Chinese population.

Authors:  Q-Y Guo; H Wang; Y Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-10       Impact factor: 3.507

7.  Polymorphisms in the H19 gene and the risk of bladder cancer.

Authors:  Gerald W Verhaegh; Linda Verkleij; Sita H H M Vermeulen; Martin den Heijer; J Alfred Witjes; Lambertus A Kiemeney
Journal:  Eur Urol       Date:  2008-02-04       Impact factor: 20.096

8.  Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population.

Authors:  Yuxiang Lin; Fangmeng Fu; Yazhen Chen; Wei Qiu; Songping Lin; Peidong Yang; Meng Huang; Chuan Wang
Journal:  Onco Targets Ther       Date:  2017-09-07       Impact factor: 4.147

9.  The contribution of XRCC3 genotypes to childhood acute lymphoblastic leukemia.

Authors:  Jen-Sheng Pei; Wen-Shin Chang; Pei-Chen Hsu; Chao-Chun Chen; Shun-Ping Cheng; Yun-Chi Wang; Chia-Wen Tsai; Te-Chun Shen; Da-Tian Bau
Journal:  Cancer Manag Res       Date:  2018-11-15       Impact factor: 3.989

10.  Genetic Polymorphisms in Long Noncoding RNA H19 Are Associated With Susceptibility to Breast Cancer in Chinese Population.

Authors:  Zongjiang Xia; Rui Yan; Fujiao Duan; Chunhua Song; Peng Wang; Kaijuan Wang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more
  3 in total

1.  Contribution of Cyclin-dependent Kinase Inhibitor 1B Genotypes to Childhood Leukemia Risk.

Authors:  Jen-Sheng Pei; Wen-Shin Chang; Pei-Chen Hsu; Chao-Chun Chen; Ya-Chen Yang; Shih-Wei Hsu; Yuan-Nian Hsu; Yun-Chi Wang; Chung-Hsing Wang; Chia-Wen Tsai; DA-Tian Bau
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

2.  Novel Contribution of Long Non-coding RNA MEG3 Genotype to Prediction of Childhood Leukemia Risk.

Authors:  Jen-Sheng Pei; Wen-Shin Chang; Chao-Chun Chen; Mei-Chin Mong; Shih-Wei Hsu; Pei-Chen Hsu; Yuan-Nian Hsu; Yun-Chi Wang; Chia-Wen Tsai; DA-Tian Bau
Journal:  Cancer Genomics Proteomics       Date:  2022 Jan-Feb       Impact factor: 4.069

3.  A Retrospective Cohort Study of the Efficacy, Safety, and Clinical Value of 6-TG versus 6-MP Maintenance Therapy in Children with Acute Lymphoblastic Leukemia.

Authors:  Minghui Tu; Aiming Zhang; Li Hu; Feng Wang
Journal:  Biomed Res Int       Date:  2022-08-21       Impact factor: 3.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.